Wednesday, November 27, 2013
In collaboration with Anacor and the Drugs for Neglected Diseases Initiative (DNDi), SCYNEXIS
recently discovered SCYX-7158 (1), a novel representative of the oxaborole class of compounds
with excellent activity against Human African ...